Owkin has no published valuation. It comes from the $180M Strategic investment of Nov 2021. The company is private, so there is no listed share price.
1 valuation. The latest, $1B post-money, was set by the Strategic investment in Nov 2021.
The closest biotech / ai peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Owkin is a private company; its shares do not trade on a public exchange.